603858 步长制药
交易中 08-10 11:18:30
资讯
新帖
简况
每周股票复盘:步长制药(603858)全资子公司完成工商变更
证券之星 · 08-09 02:20
每周股票复盘:步长制药(603858)全资子公司完成工商变更
股市必读:XD步长制新发布《山东步长制药股份有限公司关于拟对外投资设立子公司的进展公告》
证券之星 · 08-07
股市必读:XD步长制新发布《山东步长制药股份有限公司关于拟对外投资设立子公司的进展公告》
步长制药(603858)披露拟对外投资设立子公司进展公告,8月5日股价下跌0.89%
证券之星 · 08-05
步长制药(603858)披露拟对外投资设立子公司进展公告,8月5日股价下跌0.89%
股市必读:步长制药新发布《山东步长制药股份有限公司关于全资子公司完成工商变更登记的公告》
证券之星 · 08-05
股市必读:步长制药新发布《山东步长制药股份有限公司关于全资子公司完成工商变更登记的公告》
步长制药(603858)披露全资子公司完成工商变更登记公告,8月3日股价上涨1.27%
证券之星 · 08-03
步长制药(603858)披露全资子公司完成工商变更登记公告,8月3日股价上涨1.27%
每周股票复盘:步长制药(603858)末期分红1.86亿元
证券之星 · 08-02
每周股票复盘:步长制药(603858)末期分红1.86亿元
股市必读:新发布《山东步长制药股份有限公司关于控股股东部分股份解除质押及再质押的公告》
证券之星 · 07-31
股市必读:新发布《山东步长制药股份有限公司关于控股股东部分股份解除质押及再质押的公告》
步长制药:积极探索数智化技术与传统研发模式的融合
证券之星 · 07-30
步长制药:积极探索数智化技术与传统研发模式的融合
步长制药最新公告:控股子公司撤回“注射用依派促红素α”的药品注册申请
证券之星 · 07-29
步长制药最新公告:控股子公司撤回“注射用依派促红素α”的药品注册申请
股市必读:步长制药(603858)7月28日董秘有最新回复
证券之星 · 07-29
股市必读:步长制药(603858)7月28日董秘有最新回复
步长制药(603858)披露调整2025年度末期利润分配现金分红总额公告,7月28日股价下跌1.82%
证券之星 · 07-28
步长制药(603858)披露调整2025年度末期利润分配现金分红总额公告,7月28日股价下跌1.82%
步长制药(603858.SH)拟投资设立山东步长盛世制药有限公司
智通财经 · 07-28
步长制药(603858.SH)拟投资设立山东步长盛世制药有限公司
步长制药:坚持"聚焦大病种、培育大品种"战略
证券之星 · 07-28
步长制药:坚持"聚焦大病种、培育大品种"战略
每周股票复盘:步长制药(603858)全资子公司签两项医美研发合同
证券之星 · 07-26
每周股票复盘:步长制药(603858)全资子公司签两项医美研发合同
步长制药(603858)披露全资子公司药品生产许可证变更公告,7月24日股价下跌2.28%
证券之星 · 07-24
步长制药(603858)披露全资子公司药品生产许可证变更公告,7月24日股价下跌2.28%
步长制药(603858)披露全资子公司签订技术开发(委托)合同公告,7月23日股价下跌1.25%
证券之星 · 07-23
步长制药(603858)披露全资子公司签订技术开发(委托)合同公告,7月23日股价下跌1.25%
步长制药最新公告:全资子公司药品生产许可证变更完成
证券之星 · 07-23
步长制药最新公告:全资子公司药品生产许可证变更完成
步长制药(603858.SH)子公司签订两项技术开发合同
智通财经 · 07-23
步长制药(603858.SH)子公司签订两项技术开发合同
步长制药(603858)披露拟向控股子公司增资公告,7月21日股价下跌0.19%
证券之星 · 07-21
步长制药(603858)披露拟向控股子公司增资公告,7月21日股价下跌0.19%
每周股票复盘:步长制药(603858)控股子公司医疗器械经营许可变更
证券之星 · 07-19
每周股票复盘:步长制药(603858)控股子公司医疗器械经营许可变更
加载更多
公司概况
公司名称:
山东步长制药股份有限公司
所属行业:
医药制造业
上市日期:
2016-11-18
主营业务:
山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、妇科用药、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、生物药、流感病毒裂解疫苗、四价流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。
发行价格:
55.88
{"stockData":{"symbol":"603858","market":"SH","secType":"STK","nameCN":"步长制药","latestPrice":15.98,"timestamp":1786331910000,"preClose":15.95,"halted":0,"volume":5025936,"delay":0,"changeRate":0.0019,"floatShares":1055000000,"shares":1055000000,"eps":0.3546,"marketStatus":"交易中","change":0.03,"latestTime":"08-10 11:18:30","open":15.96,"high":16.16,"low":15.93,"amount":80686000,"amplitude":0.0144,"askPrice":15.98,"askSize":6,"bidPrice":15.97,"bidSize":698,"shortable":0,"etf":0,"ttmEps":0.3546,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786332600000},"marketStatusCode":2,"adr":0,"adjPreClose":15.95,"symbolType":"stock","openAndCloseTimeList":[[1786325400000,1786332600000],[1786338000000,1786345200000]],"highLimit":17.55,"lowLimit":14.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1054568442,"isCdr":false,"pbRate":1.65,"roa":"--","peRate":45.064862,"roe":"3.16%","epsLYR":0.3416,"committee":0.560771,"marketValue":16852000000,"turnoverRate":0.0048,"status":0,"floatMarketCap":16852000000},"requestUrl":"/m/hq/s/603858","defaultTab":"news","newsList":[{"id":"2658895675","title":"每周股票复盘:步长制药(603858)全资子公司完成工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2658895675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658895675?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:20","pubTimestamp":1786213220,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,步长制药报收于15.95元,较上周的15.76元上涨1.21%。本周关注点公司公告汇总:全资子公司杨凌步长制药有限公司完成工商变更登记,经营范围新增中药提取物生产、太阳能发电技术服务等。公司公告汇总山东步长制药股份有限公司全资子公司杨凌步长制药有限公司已完成工商变更登记,取得杨凌示范区市场监督管理局换发的营业执照。四川泸州步长生物制药有限公司完成首期增资扩股并办理工商变更登记,注册资本变更为4.58526316亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516306","title":"股市必读:XD步长制新发布《山东步长制药股份有限公司关于拟对外投资设立子公司的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657516306?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:00","pubTimestamp":1786039246,"startTime":"0","endTime":"0","summary":"公司公告汇总山东步长制药股份有限公司关于拟对外投资设立子公司的进展公告山东步长制药股份有限公司于2026年8月5日与济南福聚长源企业管理中心及自然人邓博睿签署《关于山东步长盛世制药有限公司之合作协议书》,拟共同设立控股子公司山东步长盛世制药有限公司。合资公司注册资本为5,000万元,步长制药认缴3,350万元,持股67%,以货币方式出资。各方约定在2031年6月21日前同比例实缴出资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657236555","title":"步长制药(603858)披露拟对外投资设立子公司进展公告,8月5日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657236555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657236555?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:26","pubTimestamp":1785939977,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,步长制药报收于15.66元,较前一交易日下跌0.89%,最新总市值为165.15亿元。该股当日开盘15.8元,最高15.88元,最低15.58元,成交额达8868.46万元,换手率为0.54%。近日,山东步长制药股份有限公司发布《关于拟对外投资设立子公司的进展公告》。合资公司注册资本为5,000万元,步长制药认缴3,350万元,持股67%,以货币方式出资。各方约定在2031年6月21日前同比例实缴出资。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603858","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657635195","title":"股市必读:步长制药新发布《山东步长制药股份有限公司关于全资子公司完成工商变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657635195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657635195?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:46","pubTimestamp":1785865575,"startTime":"0","endTime":"0","summary":"公司公告汇总山东步长制药股份有限公司关于全资子公司完成工商变更登记的公告杨凌步长制药有限公司已完成工商变更登记,取得杨凌示范区市场监督管理局换发的营业执照。山东步长制药股份有限公司关于控股子公司增资扩股引进外部投资者、发行可转债及公司放弃优先认购权暨关联交易且公司为控股子公司提供担保的进展公告四川泸州步长生物制药有限公司完成首期增资工商变更登记,注册资本变更为4.58526316亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656224377","title":"步长制药(603858)披露全资子公司完成工商变更登记公告,8月3日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656224377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656224377?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:41","pubTimestamp":1785768073,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,步长制药报收于15.96元,较前一交易日上涨1.27%,最新总市值为168.31亿元。近日,山东步长制药股份有限公司发布《关于全资子公司完成工商变更登记的公告》。公告显示,公司于2026年6月8日召开第五届董事会第五十次会议,审议通过关于全资子公司经营范围变更的议案。公司全资子公司杨凌步长制药有限公司已完成工商变更登记,并取得杨凌示范区市场监督管理局换发的营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603858","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316783","title":"每周股票复盘:步长制药(603858)末期分红1.86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316783?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:33","pubTimestamp":1785609189,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,步长制药报收于15.76元,较上周的15.44元上涨2.07%。公司公告汇总山东步长制药股份有限公司调整2025年度末期利润分配现金分红总额,因股份回购导致可参与分配股本变动。截至2026年6月30日,该项目累计研发投入约56,105.65万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655980011","title":"股市必读:新发布《山东步长制药股份有限公司关于控股股东部分股份解除质押及再质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655980011","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655980011?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:39","pubTimestamp":1785436749,"startTime":"0","endTime":"0","summary":"公司公告汇总山东步长制药股份有限公司关于控股股东部分股份解除质押及再质押的公告山东步长制药股份有限公司控股股东步长(香港)持有公司490,957,202股,占总股本46.56%。本次解除质押14,300,000股,同时再质押14,300,000股给中信金融租赁有限公司,质押用途为经营所需。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655260308","title":"步长制药:积极探索数智化技术与传统研发模式的融合","url":"https://stock-news.laohu8.com/highlight/detail?id=2655260308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655260308?lang=zh_cn&edition=full","pubTime":"2026-07-30 15:33","pubTimestamp":1785396839,"startTime":"0","endTime":"0","summary":"证券之星消息,步长制药(603858)07月30日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,公司现在由仿制药转型升级生物医药开发如艾滋病疫苗和广谱流感疫苗请问公司现在做生物医药有能运用人工智能如“Ai孔明”,“云深”等来帮助开发新药?步长制药回复:您好,感谢关注与建议。公司坚持自主技术创新与产学研合作相结合的研发模式,密切关注人工智能等新技术在医药研发领域的应用,积极探索数智化技术与传统研发模式的融合,优化研发管线布局,如有重大进展将严格按照规定及时履行信息披露义务。谢谢。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000019480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655865630","title":"步长制药最新公告:控股子公司撤回“注射用依派促红素α”的药品注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2655865630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655865630?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:40","pubTimestamp":1785318044,"startTime":"0","endTime":"0","summary":"步长制药(603858.SH)公告称,公司控股子公司泸州步长收到国家药监局通知,同意撤回“注射用依派促红素α”的药品注册申请。该药品为治疗用生物制品1类,拟用于治疗成人透析患者因慢性肾病引起的贫血。截至2026年6月30日,项目研发投入约5.61亿元。撤回原因为需完善申报资料,后续将补充后重新提交申请。公司表示,此举不会对当期业绩产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655881642","title":"股市必读:步长制药(603858)7月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655881642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655881642?lang=zh_cn&edition=full","pubTime":"2026-07-29 01:24","pubTimestamp":1785259453,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘,步长制药报收于15.62元,下跌1.82%,换手率0.62%,成交量6.55万手,成交额1.03亿元。公司公告汇总:公司拟出资3,350万元设立控股子公司山东步长盛世制药有限公司,注册资本5,000万元,持股67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900001054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883338","title":"步长制药(603858)披露调整2025年度末期利润分配现金分红总额公告,7月28日股价下跌1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883338","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654883338?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:24","pubTimestamp":1785248657,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘,步长制药报收于15.62元,较前一交易日下跌1.82%,最新总市值为164.72亿元。该股当日开盘15.92元,最高16.04元,最低15.4元,成交额达1.03亿元,换手率为0.62%。近日,山东步长制药股份有限公司发布《关于调整2025年度末期利润分配现金分红总额的公告》。本次调整基于截至公告日可参与权益分派的股本1,037,890,046股计算。2025年中期已分红411,281,692.38元(含税),加上末期分红及股份回购金额98,055,757.84元,全年现金分红与回购合计696,157,658.50元,占当年归母净利润的192.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003766","title":"步长制药(603858.SH)拟投资设立山东步长盛世制药有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654003766?lang=zh_cn&edition=full","pubTime":"2026-07-28 18:22","pubTimestamp":1785234173,"startTime":"0","endTime":"0","summary":"智通财经APP讯,步长制药(603858.SH)发布公告,公司为完善战略发展布局,在细分管理的基础上获取市场竞争优势,促进业务发展,拟对外投资设立一家控股子公司山东步长盛世制药有限公司。新设公司注册资本为5000万元,公司拟出资3350万元,持股比例为67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK0196","603858","BK1191","BK0239","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003458","title":"步长制药:坚持\"聚焦大病种、培育大品种\"战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654003458?lang=zh_cn&edition=full","pubTime":"2026-07-28 18:15","pubTimestamp":1785233717,"startTime":"0","endTime":"0","summary":"生物医药实验室自动化了公司所研发的艾滋病疫苗和广谱流感疫苗也可以早日服务于广大患者造福全人类。公司坚持\"聚焦大病种、培育大品种\"战略,在生物药及疫苗领域持续布局,目前多项产品正在研发推进中。公司研发坚持自主与合作并举,与国内外优势研发机构保持深度合作,将持续关注行业前沿动态,优化研发管线布局,如有重大进展将严格按照规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800030053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057970","title":"每周股票复盘:步长制药(603858)全资子公司签两项医美研发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057970?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:42","pubTimestamp":1785004931,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,步长制药报收于15.44元,较上周的15.56元下跌0.77%。本周关注点公司公告汇总:全资子公司保定天浩与北京新力妍签订两项注射用填充剂技术开发合同。山东步长制药股份有限公司全资子公司陕西步长高新制药有限公司和陕西步长制药有限公司近日获得陕西省药品监督管理局许可,对其《药品生产许可证》进行变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033321","title":"步长制药(603858)披露全资子公司药品生产许可证变更公告,7月24日股价下跌2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033321","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653033321?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:37","pubTimestamp":1784903833,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,步长制药报收于15.44元,较前一交易日下跌2.28%,最新总市值为162.83亿元。该股当日开盘15.8元,最高15.85元,最低15.41元,成交额达7854.94万元,换手率为0.48%。近日,山东步长制药股份有限公司发布关于公司全资子公司药品生产许可证变更的公告。公告显示,其全资子公司陕西步长高新制药有限公司和陕西步长制药有限公司获得陕西省药品监督管理局许可,对其《药品生产许可证》进行变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653729814","title":"步长制药(603858)披露全资子公司签订技术开发(委托)合同公告,7月23日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653729814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653729814?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:29","pubTimestamp":1784816954,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘,步长制药报收于15.8元,较前一交易日下跌1.25%,最新总市值为166.62亿元。近日,山东步长制药股份有限公司发布《关于全资子公司签订技术开发(委托)合同的公告》。公告显示,公司全资子公司保定天浩制药有限公司于2026年7月23日与北京新力妍生物科技有限公司签订两项《技术开发(委托)合同》,分别委托其开展注射用丝素蛋白填充剂和注射用羟基磷酸钙填充剂的研发、注册申报及受托生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603858","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653469237","title":"步长制药最新公告:全资子公司药品生产许可证变更完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2653469237","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653469237?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:04","pubTimestamp":1784801085,"startTime":"0","endTime":"0","summary":"步长制药(603858.SH)公告称,公司全资子公司通化谷红制药有限公司近日获得吉林省药品监督管理局许可,同意其《药品生产许可证》分类码变更为AhzBhCh,并接受委托生产依达拉奉右莰醇注射用浓溶液。此次变更有利于优化生产结构,满足市场需求,对公司未来经营产生积极影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300037205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653449743","title":"步长制药(603858.SH)子公司签订两项技术开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2653449743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653449743?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:29","pubTimestamp":1784798995,"startTime":"0","endTime":"0","summary":"智通财经APP讯,步长制药 发布公告,2026年7月23日,公司全资子公司保定天浩制药有限公司与北京新力妍生物科技有限公司签订两项《技术开发(委托)合同》,委托北京新力妍按照国家现行《医疗器械注册管理办法》及相关技术指导原则,开展注射用丝素蛋白填充剂与注射用羟基磷酸钙填充剂的研发、注册申报、受托生产等合作事宜。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0196","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653320596","title":"步长制药(603858)披露拟向控股子公司增资公告,7月21日股价下跌0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653320596","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653320596?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:21","pubTimestamp":1784643668,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘,步长制药报收于15.8元,较前一交易日下跌0.19%,最新总市值为166.62亿元。该股当日开盘15.8元,最高16.19元,最低15.7元,成交额达1.52亿元,换手率为0.91%。近日,山东步长制药股份有限公司发布《关于拟向控股子公司增资的公告》。公告显示,公司拟与控股子公司济南步长瀛玺商贸有限公司其他股东按现有持股比例,以现金方式共同增资400万元人民币,其中公司出资360万元。公司董事会已审议通过该事项,无需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652308062","title":"每周股票复盘:步长制药(603858)控股子公司医疗器械经营许可变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2652308062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652308062?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:17","pubTimestamp":1784398628,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,步长制药报收于15.56元,较上周的15.49元上涨0.45%。本周关注点来自公司公告汇总:控股子公司上海合璞医疗完成医疗器械经营许可证变更,经营范围扩大至多类三类器械及体外诊断试剂。公司公告汇总山东步长制药股份有限公司控股子公司上海合璞医疗科技有限公司近日完成《医疗器械经营许可证》的变更登记,变更内容包括经营范围和库房地址。步长(香港)累计质押股份101,530,000股,占其所持股份的20.68%,占公司总股本的9.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","603858","09996","BK0239","BK1574","BK1583","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786331923873,"stockEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0034},{"period":"6month","weight":-0.0716},{"period":"1year","weight":-0.086},{"period":"ytd","weight":0.0316}],"compareEarnings":[{"period":"1week","weight":0.0281},{"period":"1month","weight":-0.0078},{"period":"3month","weight":-0.0574},{"period":"6month","weight":-0.0309},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0073}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东步长制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"51168人(较上一季度减少2.91%)","perCapita":"20609股","listingDate":"2016-11-18","address":"山东省菏泽市牡丹区中华西路369号","registeredCapital":"105456万元","survey":" 山东步长制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是脑心通胶囊、稳心颗粒、丹红注射液、妇科用药、前列舒通胶囊、宣肺败毒颗粒、复方脑肽节苷脂注射液、复方曲肽注射液、谷红注射液、银杏蜜环口服溶液、生物药、流感病毒裂解疫苗、四价流感病毒裂解疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗。公司名列“2023年度中国中药企业TOP100排行榜”第四位。","listedPrice":55.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"步长制药,603858,步长制药股票,步长制药股票老虎,步长制药股票老虎国际,步长制药行情,步长制药股票行情,步长制药股价,步长制药股市,步长制药股票价格,步长制药股票交易,步长制药股票购买,步长制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}